BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19280235)

  • 1. Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia.
    Bruns AH; Oosterheert JJ; Hustinx WN; Gaillard CA; Hak E; Hoepelman AI
    Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):913-9. PubMed ID: 19280235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.
    Waterer GW; Kessler LA; Wunderink RG
    Chest; 2006 Jul; 130(1):11-5. PubMed ID: 16840376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes.
    Bordon J; Aliberti S; Duvvuri P; Wiemken T; Peyrani P; Natividad I; Caceres-Lara A; Delapenha R; Blasi F; Ramirez J
    Int J Infect Dis; 2013 May; 17(5):e293-8. PubMed ID: 23507237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia.
    Yahav D; Leibovici L; Goldberg E; Bishara J; Paul M
    Int J Antimicrob Agents; 2013 May; 41(5):410-3. PubMed ID: 23453615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine.
    Pines JM; Isserman JA; Hinfey PB
    J Emerg Med; 2009 Oct; 37(3):335-40. PubMed ID: 19717266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic timing and errors in diagnosing pneumonia.
    Welker JA; Huston M; McCue JD
    Arch Intern Med; 2008 Feb; 168(4):351-6. PubMed ID: 18299488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
    Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
    Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency department crowding is associated with 28-day mortality in community-acquired pneumonia patients.
    Jo S; Kim K; Lee JH; Rhee JE; Kim YJ; Suh GJ; Jin YH
    J Infect; 2012 Mar; 64(3):268-75. PubMed ID: 22227383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores.
    Viasus D; Garcia-Vidal C; Castellote J; Adamuz J; Verdaguer R; Dorca J; Manresa F; Gudiol F; Carratalà J
    Medicine (Baltimore); 2011 Mar; 90(2):110-118. PubMed ID: 21358441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.
    Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
    Eur Respir J; 2006 Jun; 27(6):1210-6. PubMed ID: 16510452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-reported data on the pneumonia quality measure "Time to First Antibiotic Dose" are not associated with inpatient mortality: results of a nationwide cross-sectional analysis.
    Quattromani E; Powell ES; Khare RK; Cheema N; Sauser K; Periyanayagam U; Pirotte MJ; Feinglass J; Mark Courtney D
    Acad Emerg Med; 2011 May; 18(5):496-503. PubMed ID: 21545670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.
    Wongsurakiat P; Chitwarakorn N
    BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia.
    Franzen D; Lim M; Bratton DJ; Kuster SP; Kohler M
    Lung; 2016 Oct; 194(5):769-75. PubMed ID: 27405854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation.
    Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Matsui H; Fushimi K; Nagase T
    Respir Investig; 2017 Jan; 55(1):39-44. PubMed ID: 28012492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antibiotic therapy in severe community-acquired pneumonia: Data from the Infauci study.
    Pereira JM; Gonçalves-Pereira J; Ribeiro O; Baptista JP; Froes F; Paiva JA
    J Crit Care; 2018 Feb; 43():183-189. PubMed ID: 28915392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.